Every March 26 is Purple Day worldwide, a day that raises awareness for epilepsy, an often poorly understood affliction that affects millions of people across the globe. Epilepsy itself is defined as a condition of the brain that is characterized by recurrent seizures. For years, the scientific community has strived to develop treatments to prevent seizures and determine the underlying causes of epilepsy with varying degrees of success; while some patients respond well to pharmaceutical treatment, others present intractable epilepsy.

Some people have turned to medical cannabis as an alternative to conventional pharmaceuticals when these fail. However, the scientific community has not yet arrived at any consensus regarding the efficacy of cannabis for the treatment of epilepsy. At Tilray, we have had the privilege of working with such patients, and in addition, we’re currently exploring ways to help the ongoing investigation into how medical cannabis could help people with epilepsy manage their symptoms.

Below, we present original research underway into the potential use of medical cannabis for epilepsy.

Medical Cannabis for Epilepsy: Current research
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
The case for assessing cannabidiol in epilepsy
Marijuana use and epilepsy
A Cannabis Derivative for Treatment-Resistant Epilepsy?
Cannabinoids in the Treatment of Epilepsy